90 related articles for article (PubMed ID: 21817853)
1. A recombinant mutant abrin A chain expressed in Escherichia coli can be used as an effective vaccine candidate.
Han YH; Gao S; Xin WW; Kang L; Wang JL
Hum Vaccin; 2011 Aug; 7(8):838-44. PubMed ID: 21817853
[TBL] [Abstract][Full Text] [Related]
2. Truncated abrin A chain expressed in Escherichia coli: a promising vaccine candidate.
Zhang T; Kang L; Gao S; Yang H; Xin W; Wang J; Guo M; Wang J
Hum Vaccin Immunother; 2014; 10(9):2648-55. PubMed ID: 25483485
[TBL] [Abstract][Full Text] [Related]
3. A novel recombinant vaccine protecting mice against abrin intoxication.
Wang J; Gao S; Xin W; Kang L; Xu N; Zhang T; Liu W; Wang J
Hum Vaccin Immunother; 2015; 11(6):1361-7. PubMed ID: 26086588
[TBL] [Abstract][Full Text] [Related]
4. A recombinant chimeric protein containing B chains of ricin and abrin is an effective vaccine candidate.
Wang J; Gao S; Zhang T; Kang L; Cao W; Xu N; Liu W; Wang J
Hum Vaccin Immunother; 2014; 10(4):938-44. PubMed ID: 24509607
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of three abrin A-chains and their mutants derived by site-specific mutagenesis in Escherichia coli.
Hung CH; Lee MC; Chen JK; Lin JY
Eur J Biochem; 1994 Jan; 219(1-2):83-7. PubMed ID: 8307038
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.
Yu YZ; Li N; Wang RL; Zhu HQ; Wang S; Yu WY; Sun ZW
Clin Vaccine Immunol; 2008 Dec; 15(12):1819-23. PubMed ID: 18845829
[TBL] [Abstract][Full Text] [Related]
7. A chimeric protein of abrin and Abrus precatorius agglutinin that neutralizes abrin mediated lethality in mice.
Tiwari V; Bagaria S; Karande AA
Toxicon; 2017 Mar; 127():122-129. PubMed ID: 28088476
[TBL] [Abstract][Full Text] [Related]
8. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
9. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
[TBL] [Abstract][Full Text] [Related]
10. Gene cloning, expression and vaccine testing of Schistosoma japonicum SjFABP.
Liu JM; Cai XZ; Lin JJ; Fu ZQ; Yang GZ; Shi FH; Cai YM; Shen W; Taylor MG; Wu XF
Parasite Immunol; 2004; 26(8-9):351-8. PubMed ID: 15679632
[TBL] [Abstract][Full Text] [Related]
11. [Mucosal immunization of recombinant Schistosoma japonicum ferritin].
Chen LY; Yi XY; Zeng XF; Zhang SK; McReynolds L
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):129-32. PubMed ID: 15597704
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.
Turner AK; Terry TD; Sack DA; Londoño-Arcila P; Darsley MJ
Infect Immun; 2001 Aug; 69(8):4969-79. PubMed ID: 11447175
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate.
Yu YZ; Gong ZW; Ma Y; Zhang SM; Zhu HQ; Wang WB; Du Y; Wang S; Yu WY; Sun ZW
Vaccine; 2011 Aug; 29(35):5978-85. PubMed ID: 21718736
[TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice.
Choi AH; Basu M; McNeal MM; Bean JA; Clements JD; Ward RL
Protein Expr Purif; 2004 Dec; 38(2):205-16. PubMed ID: 15555936
[TBL] [Abstract][Full Text] [Related]
15. A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein.
Lin HX; Huang DY; Wang Y; Lu CP; Fan HJ
Vaccine; 2011 Sep; 29(40):7027-34. PubMed ID: 21807055
[TBL] [Abstract][Full Text] [Related]
16. [Particulate recombinant hepatitis E virus capsid protein and its antigenicity and immunogenicity].
He ZQ; Zhang J; Li SW; Lin J; Liu RS; Chen YX; Wang YB; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):262-8. PubMed ID: 15969119
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression of the abrin-a A-chain in Escherichia coli and measurement of the biological activities in vitro.
Qing LT; Qu XL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):405-10. PubMed ID: 12098760
[TBL] [Abstract][Full Text] [Related]
18. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
[TBL] [Abstract][Full Text] [Related]
19. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
